Issue of Employee Shares and Rights
Stride Property Group (NS)
NZX Announcement
12 November 2025
W strideproperty.co.nz
Stride Property Group
Issue of Rights Pursuant to Employee Incentive Schemes
Stride Investment Management Limited (SIML) advises that it has today:
(a) issued 30,671 rights to Claire Fisher, General Manager Corporate Services, pursuant to
the executive long term incentive scheme for FY26 (the period 1 April 2025 to 31 March
2028); and
(b) issued 24,472 rights to Claire Fisher, General Manager Corporate Services as part of her
FY26 fixed remuneration compensation. These rights vest after 31 March 2027, if she
remains employed by SIML at that time.
Upon vesting, each right converts into one Stapled Security of the Stride Property Group.
Attached are capital change notices related to the grant of rights pursuant to Listing Rule 3.13.1.
End
For further information please contact:
Tim Storey, Chairman, Stride Investment Management Limited / Stride Property Limited
Mobile: 021 633 089 - Email: tim.storey@strideproperty.co.nz
Philip Littlewood, Chief Executive Officer, Stride Investment Management Limited
Mobile: 021 230 3026 - Email: philip.littlewood@strideproperty.co.nz
Jennifer Whooley, Chief Financial Officer, Stride Investment Management Limited
Mobile: 021 536 406 - Email: jennifer.whooley@strideproperty.co.nz
A Stapled Security of the Stride Property Group comprises one ordinary share in Stride Property Limited and
one ordinary share in Stride Investment Management Limited. Under the terms of the constitution of each
company, the shares in each can only be transferred if accompanied by a transfer of the same number of
shares in the other.
Stapled Securities are quoted on the NZX Main Board under the ticker code SPG. Further information is
available at www.strideproperty.co.nz or at www.nzx.com/companies/SPG.
---
Template
Capital Change Notice
Updated as at February 2025
Please do not amend or delete individual rows. As this template relates to prescribed content, changes to content
should only be made where it is clearly indicated that this is permitted, otherwise, if an Issuer considers a particular
element does not apply, mark the row as N/A. Any other changes to this prescribed form must first be approved by
NZX as required under NZX Listing Rule 3.26.1.
Section 1: Issuer information
Name of issuer Stride Property Group
NZX ticker code SPG
Class of financial product Rights to Ordinary Shares in each of
Stride Investment Management Limited
and Stride Property Limited
ISIN (If unknown, check on NZX website) N/A
Currency N/A
Section 2: Capital change details
Number issued/acquired/redeemed 55,143
Nominal value (if any) N/A
Issue/acquisition/redemption price per security N/A
Nature of the payment (for example, cash or other
consideration)
N/A
Amount paid up (if not in full) N/A
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the
number of Financial Products of the Class,
excluding any Treasury Stock, in existence)
1
1.2% of total Rights on issue immediately
before the issue (following forfeiture of
Rights).
If all Rights the subject of this notice were
converted to shares in Stride Investment
Management Limited and Stride Property
Limited (if all conditions to the issue of
those shares were met), such shares
would represent 0.01% of the total shares
on issue (based upon the number of
shares on issue as at the date of this
notice).
For an issue of Convertible Financial Products or
Options, the principal terms of Conversion (for
example the Conversion price and Conversion date
and the ranking of the Financial Product in relation
to other Classes of Financial Product) or the Option
(for example, the exercise price and exercise date)
N/A
Reason for issue/acquisition/redemption and
specific authority for issue/acquisition/redemption/
(the reason for change must be identified here)
Rights issued pursuant to the long term
incentive plan for SIML and in connection
with FY26 remuneration
Total number of Financial Products of the Class
after the issue/acquisition/redemption/Conversion
4,817,202
1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.
(excluding Treasury Stock) and the total number of
Financial Products of the Class held as Treasury
Stock after the issue/acquisition/redemption.
In the case of an acquisition of shares, whether
those shares are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or
redemption, including a reference to the rule
pursuant to which the issue, acquisition, or
redemption is made
Board resolutions dated 16 October 2025
for an issue made pursuant to Listing Rule
4.6.1
Terms or details of the issue, acquisition, or
redemption (for example: restrictions, escrow
arrangements)
Long term incentive Rights are issued in
accordance with the SIML long term
incentive plan and will vest and convert
into Ordinary Shares, subject to the
conditions set out in the long term
incentive plan rules being met.
The Rights issued in connection with the
FY26 remuneration grant are issued in
accordance with the letters provided to the
holders. For the FY26 remuneration rights
to vest and convert into Ordinary Shares,
the holder must continue to be employed
on 31 March 2027.
Date of issue/acquisition/redemption
2
12/11/2025
Section 3: Disclosure required for Placements made under Rule 4.5.1
[Issuers may opt to release Section 3 information (if not already done so) in a separate announcement within five Business Days of
the issuance. Delete this Section 3 if capital change is not the result of a Placement under Rule 4.5.1]
Details of the approach in identifying investors who
were able to participate in the offer and how their
respective allocations in the offer were determined.
The explanation must set out the key objectives
and criteria the Issuer adopted in the allocation
process, whether one of those objectives was a
best effort to allocate on a pro rata basis to existing
holders of the Issuer’s Equity Securities, and any
significant exceptions or deviations from those
objectives and criteria.
N/A
Section 4: Authority for this announcement and contact person
Name of person
authorised to make this
announcement
Jennifer Whooley
Contact person for this announcement Jennifer Whooley
Contact phone number 021536406
Contact email address jennifer.whooley@strideproperty.co.nz
Date of release through MAP
12/11/2025
2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- FPH — Fisher & Paykel Healthcare Corporation Limited: Capital Change Notice - Issue of Ordinary Shares2025-09-09
“Capital Change Notice 9 September 2025 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) under the Fisher & Paykel Healthcare Employee Sha…”
- PFI — Property for Industry Limited: Capital Change Notice - FY2025 LTI Scheme Vesting2025-08-25
“Capital Change Notice Updated as at February 2025 Section 1: Issuer information Name of issuer Property for Industry Limited NZX ticker code PFI Class of financial product Ordinary Shares ISIN (If unknown, check on NZX website) NZPFIE0001S5 Currency NZD Section 2: Ca…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Capital Change Notice - Issue of Employee Share Rights2025-09-04
“Capital Change Notice 5 September 2025 Issue of Employee Share Rights This notice is given under NZX Listing Rule 3.13.1 and relates to unlisted Employee Share Rights to acquire ordinary shares in the Company (‘ESRs’) issued under the Fisher & Paykel Healthcare Employee Sh…”